Followers | 374 |
Posts | 16851 |
Boards Moderated | 4 |
Alias Born | 03/07/2014 |
Friday, August 01, 2014 7:42:16 PM
There is little or no "trial" spending going on, as the total "R&D" expense line is about $5K a month. Look at past filings when they were running actual "trials", as in FDA type trials. That R&D line was many multiples of that. Just in the same period 2013, it was $172K versus this paltry $15K.
They can't "hide" or "wash" supposed "trial spending" under some mysterious part of their financial statements or hidden place in the 10-Q? That's not how it works.
There's some good web sites and good books at any library on reading and understanding things like basic "financials" (commonly known as a set of financials or financial statements for a business)- typically a balance sheet, an income statement, a statement of cash flows and probably stockholder's equity. There's a few variations, but those are the jest of a typical set of "financials". That's the "snap shot" of pretty much everything key in terms of money coming in, money going out, expenses, income/revenue, interest paid, short and long term debt, etc. In this 10-Q filing, it's pretty much pages 4, 5, 6 and 7. Read those.
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM